Avidity biosciences announces upcoming presentations at the muscular dystrophy association (mda) clinical & scientific conference

Aravindhan veerapandiyan, md, associate professor of pediatrics, university of arkansas for medical sciences and arkansas children's hospital and explore44 ® trial investigator, will present topline del-zota data from phase 1/2 explore44 trial at 2025 mda clinical & scientific conference in dallas, texas avidity to host investor and analyst webcast event march 17, 2025, at 8:00 a.m. et key opinion leaders to participate in avidity sponsored industry forum event "advancing rna therapeutics", march 17, 2025, at 7:00 a.m.
RNA Ratings Summary
RNA Quant Ranking